Laway Bashir Ahmad, Goswami Ravinder, Singh Namrata, Gupta Nandita, Seith Ashu
Department of Endocrinology and Metabolism, All India Institute of Medical Sciences, New Delhi 110029, India.
Clin Endocrinol (Oxf). 2006 Apr;64(4):405-9. doi: 10.1111/j.1365-2265.2006.02479.x.
Measurement of bone mineral density (BMD) in patients with hypoparathyroidism directly addresses the effect of chronic under-exposure of bone to PTH. Because post-thyroidectomy hypoparathyroidism is potentially complicated by the pre-existence of thyrotoxicosis and the need for postoperative thyroxine replacement, we have studied a large group of patients with sporadic hypoparathyroidism who have been followed up in our endocrine clinic. Studies conducted in limited number of patients with sporadic idiopathic hypoparathyroidism (SIH) have suggested an increase in BMD in such patients. In this current study, we have measured BMD in a large cohort of patients with SIH and have assessed the relationship of BMD with duration of disease and with the adequacy of treatment, as indicated by follow-up serum calcium, phosphate and alkaline phosphatase levels.
Case control study and intra-group comparison.
Forty-seven patients (M : F ratio 23 : 24) with SIH who had been reviewed during 2003-2004 in our endocrine clinic were recruited for this study. Their mean age (+/- SD) was 34.6 +/- 13.6 years and the duration from the time of initial diagnosis was 9.6 +/- 8.5 years. Forty-eight match healthy volunteers were recruited from hospital staff and from normocalcaemic relatives.
Bone mineral density was measured at total lumbar spine (L1-L4), hip and forearm by dual energy X-ray absorptiometry (DXA). The relationship of BMD was analysed with duration of disease symptoms (group I, < or = 1 year, group II, > 1 and < 5 years and group III, > or = 5 years) and mean serum total calcium observed during follow-up (group A, calcium < or = 1.79 mmol/l and group B, > or = 1.80 mmol/l).
Patients with SIH showed significantly higher BMD at total lumbar spine and hip when compared to controls (1.098 +/- 0.187 vs. 0.936 +/- 0.131 g/cm2 and 0.967 +/- 0.141 vs. 0.882 +/- 0.149 g/cm2, P < 0.001 for both). BMD in the forearm was not significantly different in patients and controls. The age- and BMI-adjusted lumbar spine BMD showed correlation with duration of disease (r = 0.348 and P = 0.019). Patients with longer duration of hypoparathyroidism had higher BMD at lumbar spine (group I vs. group III, 0.951 +/- 0.132 vs. 1.156 +/- 0.180 g/cm2, P < 0.05). There was no significant correlation between BMD values in patients with SIH and their mean serum total calcium levels during the period of follow-up (r = 0.192, P = 0.206). Neither was the mean BMD significantly different between group A and B. Serum total alkaline phosphatase showed a significant negative correlation with BMD at lumbar spine (r = -0.445, P = 0.012).
Patients with sporadic idiopathic hypoparathyroidism have increased mean BMD in the lumbar spine and hip but not in the forearm, compared to normal matched healthy controls. The increase in BMD is related to the duration of the disease rather than the serum calcium levels.
测量甲状旁腺功能减退患者的骨密度(BMD)可直接反映骨骼长期暴露于甲状旁腺激素不足的影响。由于甲状腺切除术后的甲状旁腺功能减退可能因术前存在甲状腺毒症以及术后需要补充甲状腺素而变得复杂,我们对一大组散发性甲状旁腺功能减退患者进行了研究,这些患者在我们的内分泌门诊接受随访。对少数散发性特发性甲状旁腺功能减退(SIH)患者的研究表明,此类患者的骨密度有所增加。在本研究中,我们测量了一大组SIH患者的骨密度,并评估了骨密度与疾病持续时间以及治疗充分性的关系,治疗充分性通过随访血清钙、磷和碱性磷酸酶水平来表示。
病例对照研究和组内比较。
本研究招募了47例2003年至2004年期间在我们内分泌门诊接受检查的SIH患者(男女比例为23:24)。他们的平均年龄(±标准差)为34.6±13.6岁,从初次诊断时起的病程为9.6±8.5年。从医院工作人员和血钙正常的亲属中招募了48名匹配的健康志愿者。
采用双能X线吸收法(DXA)测量腰椎(L1-L4)、髋部和前臂的骨密度。分析骨密度与疾病症状持续时间(I组,≤1年;II组,>1年且<5年;III组,≥5年)以及随访期间观察到的平均血清总钙水平(A组,钙≤1.79 mmol/L;B组,≥1.80 mmol/L)之间的关系。
与对照组相比(分别为1.098±0.187 vs. 0.936±0.131 g/cm²和0.967±0.141 vs. 0.882±0.149 g/cm²,两者P均<0.001),SIH患者腰椎和髋部的骨密度显著更高。患者和对照组在前臂的骨密度无显著差异。经年龄和体重指数调整后的腰椎骨密度与疾病持续时间相关(r = 0.348,P = 0.019)。甲状旁腺功能减退持续时间较长的患者腰椎骨密度较高(I组与III组比较,0.951±0.132 vs. 1.156±0.180 g/cm²,P<0.05)。SIH患者的骨密度值与随访期间的平均血清总钙水平之间无显著相关性(r = 0.192,P = 0.206)。A组和B组之间的平均骨密度也无显著差异。血清总碱性磷酸酶与腰椎骨密度呈显著负相关(r = -0.445,P = 0.012)。
与正常匹配的健康对照组相比,散发性特发性甲状旁腺功能减退患者腰椎和髋部的平均骨密度增加,但前臂未增加。骨密度的增加与疾病持续时间有关,而非血清钙水平。